AMS BioteQ has started the journey since 2018, we mainly focus on drug research and development, as well as are committed to the development and technology patenting of medical fungi. We are a tiny team with gigantic ambition, and we expect to be a trendsetter instead of a follower. If you know us more, not too hard to find we are natural practitioners, trying out all kinds of crazy ideas that others can't or don't.
"The invaluable research comes from innovation, and all our endeavor lies in creating the most profitable compounds"
All creatures come from Mother Nature. AMS BioteQ explores the meaning of each ingredient out of nature, finding the dynamic connection between molecules, breaking through the limitations of existing research and development, and finally we use our strength to make contributions in the future pharmaceutical industry.
AMS BioteQ is rooted from Taiwan, our priority is to create core technologies and develop new antibiotics against multiple superbugs and viruses. It's imperative to connect with the international community and we have faith AMS BioteQ will become one of the leading brands in the biomedical industry.
R&D technology is an important asset and energy of AMS BioteQ, we focus on every instantaneous change of biotechnology, pay attention to the pulse of the international pharmaceutical situation, and actively layout the future market patenting process, the company's intellectual property adopts the PDCA management model to ensure that the research results are effectively transformed into industrial services with market value in the future.